Valley of the Sun, AZ

Working with the community... for a healthier community.

Collaborating in Alzheimer’s Disease Research

  August 07, 2018


Alzheimer’s is an irreversible disease of the brain that robs people of their memories, thinking ability, personality, and eventually leads to death. Alzheimer’s is considered a disease of aging. According to published reports, some 500,000 new cases of Alzheimer’s disease will be diagnosed in the United States this year. This disease affects more than 5 million Americans, a number that’s expected to balloon to 13.8 million by 2050.

As the sixth leading cause of death in the United States, Alzheimer’s disease is the only major chronic disease growing at an epidemic rate with no disease-modifying treatments available. The disease is of such great concern that the U.S. government passed the National Alzheimer’s Project Act in 2011 with the goal of finding a way to prevent and effectively treat Alzheimer’s disease by 2025, while also calling on those affected and working in the field of Alzheimer’s care to increase public awareness.

The role of research
Research provides us with a better understanding of how the brain ages both normally and abnormally. It also helps us determine how genetic, molecular, cellular, and environmental factors interact and either promote Alzheimer’s or possibly prevent it.

Research will also identify biomarkers and other diagnostic tools needed for early detection of cognitive decline before it leads to an Alzheimer’s diagnosis. Early detection can lead to individuals receiving earlier treatments and interventions in an effort to prevent or delay the disease.

The only way we will find an effective treatment or cure for Alzheimer’s disease is through clinical trials. There is no other way. It’s critically important for there to be the ongoing development of multiple research pathways to try to treat Alzheimer’s disease, but we also need a willing pool of individuals with and without Alzheimer’s to volunteer and help us find effective treatments and a possible cure.

Clinical trials are the primary way that researchers find out if a promising treatment is safe. Clinical trials tell researchers which treatments are the most effective and for which people they may work best.

Enter cognitive clinical trials
Cognitive Clinical Trials (CCT) is a new Phoenix-based Alzheimer’s clinical trials company that is fundamentally changing the way clinical trials are performed. The company has created a new research model that overcomes many of the obstacles currently facing Alzheimer’s research. “Conducting Alzheimer’s trials presents a different set of challenges,” said CJ Anderson, President of Cognitive Clinical Trials.

“We’ve found a way to knock down those barriers to entry for patients, as well as medical providers, so we can create a pathway for finding a cure.”

CCT’s model brings clinical trials directly to patients who may otherwise be unable to participate due to concerns over travel, scheduling, or health conditions. This is accomplished by embedding a clinical research infrastructure within established senior living communities. The infrastructure includes a clinic staffed by physicians, clinical research coordinators, and other research professionals.

Through its network of embedded sites, CCT gives trial sponsors an opportunity to create faster and more efficient ways to get the critical data that may lead to new treatments and a cure. By partnering with senior living communities, we’re helping the medical field advance Alzheimer’s research while providing residents easy access to professional treatment and care.

CCT knows its strength lies in innovation and partnerships. CCT’s leadership has put a premium on both of these things. First, connecting with people with dementia and their caregivers, family, and friends with access to participate in leading-edge therapies and clinical trials. Secondly, by embedding operations within exceptional senior living communities, like LivGenerations, creates a platform and a pathway to advance clinical research and lead people to the best treatments and care. Lastly, partnering with Dementia Care Education to educate both public and private entities about the disease and the developments and progress of dementia research.

Each clinical research discovery is another chink in the disease’s armor, pointing to new targets, treatments, and best practices. “By using education and our innovative clinical research strategy, we are paving the way to have a preventative therapy or cure in the near future. The only way we can find these treatments is to have people participate in clinical trials,” Anderson said.

Rapid advances in our knowledge about Alzheimer’s have led to the development of many promising new drugs and treatment strategies. However, before these new strategies can be used in clinical practice, they must be shown to work via clinical trials. This means that clinical trials and volunteer participants are an essential part of Alzheimer’s disease research.

The cost of Alzheimer’s is significant and only getting worse. Total payments for healthcare, long-term care, and hospice for people with Alzheimer’s disease and other dementias are projected to increase from $259 billion in 2017 to more than $1 trillion in 2050.

Behind every medicine and intervention that people have ever taken are thousands of people who have volunteered to participate in clinical trials, which have led to cures and many breakthroughs in disease prevention and treatment in the last half-century. Without the willingness of these individuals, millions would have suffered and died unnecessarily.

CCT is poised to be part of the solution to finding effective treatments and bringing down the cost of care. We are looking for people who want to participate in clinical trials, people who want to leave a legacy — they are the heroes that will help us develop the new drugs, devices, and treatments for the future and improve the care of Americans and people throughout the world.

CCT will be having open houses throughout the valley at our partner senior living communities with unprecedented access to information and education. We have a signature open house coming up at LivGenerations Ahwatukee. Please contact us or follow us on Facebook for more information about this event.

For more information about CCT or clinical trials, please contact BiancaChacon@cctresearch.com or call 480-702-3500.

LivGenerations Senior Living offers vibrant living with an extensive array of services and amenities for independent living, assisted living and memory care residents, giving them the freedom to enjoy what matters most. Stop in or call to schedule a tour of our communities: Agritopia in Gilbert, 480-485-2000, located at 2811 E. Agritopia Loop S.; Ahwatukee, 480-485-3000, located at 15815 South 50th Street;
and coming soon to Pinnacle Peak, 480-485-4000, located at 23733 N. Scottsdale Road. Email us at info@generationsseniorliving.com or find us on the web at www.livgenerations.com.

Back to Top

August 07, 2018
Categories:  Feature
Keywords:  Feature Story

 

Copyright © Agility Inc. 2019